NIH-funded research Fellowship grant

Investigating how a specific protein affects brain function and developmental disorders in children

Official title: The Role of H3K79 Methylation and Dot1L in Neuronal Function and Neurodevelopmental Disorders

Funded at University of Pennsylvania · NIH-10934334 · Data updated 2026-11-12

This study is looking at a protein called Dot1L in the brain to see how it might affect conditions like autism and developmental delays, using a special mouse model to learn more about how it influences brain development and function.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2023
Project endSeptember 30, 2025
Funding year2024
Award (this year)$36,651
NIH project number5F31NS129242-02
Project IDNIH-10934334 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years who are diagnosed with autism spectrum disorder or other neurodevelopmental disorders.

Less likely to help

Patients who are older than 11 years or do not have neurodevelopmental disorders may not benefit from this research.

What this research studies

This research focuses on understanding the role of a protein called Dot1L in the brain and its impact on neurodevelopmental disorders such as autism and developmental delays. The researchers will study how changes in Dot1L affect gene expression in neurons, particularly genes related to synaptic function. By using a special mouse model, they aim to uncover the mechanisms by which Dot1L influences brain development and function, which could lead to new insights into these disorders.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential treatments for neurodevelopmental disorders in children.

How similar studies have gone: Previous research has shown that understanding chromatin regulators like Dot1L can provide valuable insights into neurodevelopmental disorders, indicating a promising avenue for this investigation.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Maroni, Marissa — University of Pennsylvania
  • Study coordinator: Maroni, Marissa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.